Tengion Launches First Phase II Clinical Trial Of Regenerated Human Organ

... Tengion, Inc., announced today it has initiated a Phase II multi-center clinical study for its urinary neo- bladder construct. The study is being conducted in pediatric patients with spina bifida who have failing bladders that predispose them to a risk of kidney failure and incontinence even when they receive optimal medical therapy. [click link for full article] ...